Inflammatory markers, including TNF-α, IL-6, and high-sensitivity CRP, show elevated levels in diabetic neuropathy but typically achieve lower diagnostic performance (AUC 0.65-0.75) compared to our NSE results (AUC 0.863) [25]. This evidence concerns the gene CRP and diabetic neuropathy.